ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 151 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $796,000 | -38.2% | 9,310 | -16.2% | 0.32% | -38.4% |
| Q2 2018 | $1,288,000 | +8.1% | 11,115 | -24.5% | 0.52% | +2.4% |
| Q1 2018 | $1,191,000 | +1.7% | 14,715 | -26.2% | 0.51% | +11.1% |
| Q4 2017 | $1,171,000 | -1.8% | 19,950 | -21.8% | 0.46% | -9.5% |
| Q3 2017 | $1,193,000 | +0.5% | 25,500 | -22.7% | 0.51% | -0.4% |
| Q2 2017 | $1,187,000 | +16.8% | 33,000 | 0.0% | 0.51% | +7.6% |
| Q1 2017 | $1,016,000 | -8.1% | 33,000 | 0.0% | 0.47% | -17.3% |
| Q4 2016 | $1,106,000 | +26.0% | 33,000 | 0.0% | 0.57% | +28.9% |
| Q3 2016 | $878,000 | – | 33,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |